• Explore /
  • Poster
  • / Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress.

Primary cytoreductive surgery with or without Hyperthermic Intraperitoneal Chemotherapy (HIPEC) for FIGO stage III epithelial ovarian cancer: The OVHIPEC-2 trial in progress.

Abstract Video & Slides Poster

Authors

null

Ruby M. van Stein

The Netherlands Cancer Institute, Amsterdam, Netherlands

Ruby M. van Stein , Simone N. Koole , Karolina Sikorska , Desmond P. Barton , Lewis Perrin , Donal Brennan , Oliver Zivanovic , Berit J. Mosgaard , Anna Fagotti , Pierre-Emmanuel Colombo , Valesca P. Retel , Gabe S. Sonke , Willemien J. Van Driel

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2020 ASCO Virtual Scientific Program

Session Type

Poster Session

Session Title

Gynecologic Cancer

Track

Gynecologic Cancer

Sub Track

Ovarian Cancer

Clinical Trial Registration Number

NCT03772028

Citation

J Clin Oncol 38: 2020 (suppl; abstr TPS6100)

DOI

10.1200/JCO.2020.38.15_suppl.TPS6100

Abstract #

TPS6100

Poster Bd #

271

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

A phase 3 trial of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer.

First Author: Willemien Van Driel

First Author: S.P. Somashekhar

First Author: Oliver Zivanovic

First Author: Robert Allen Burger